We’re getting funded!
Funding is what keeps our lab doors open and lets us do the cutting-edge research advancing knowledge on the biology behind neurodegenerative diseases that leads to novel treatments. This year, we received several new grants to support our work.
Drs. David Butler and Anne Messer received a grant from the Michael J. Fox Foundation on their intrabody work in the context of Parkinson’s disease. Dr. Butler also obtained a grant from CurePSP to develop intrabody therapeutics for the buildup of the disease-causing tau fibrils.
Drs. Nathan Boles and Thomas Kiehl received an R21 award from the National Institute of General Medical Sciences to develop a new technique for spatial transcriptomics.
Dr. Meysam Yazdankhah was funded by The Association for FrontoTemporal Dementia (AFTD) to study the role of autophagy in neurodegeneration.
Dr. Liz Fisher received a postdoctoral fellowship from the Alzheimer’s Association to study interactions between microglia and endothelial cells in the context of Alzheimer’s Disease.
We are grateful to these amazing organizations for their commitment to improving the lives of people experiencing neurodegenerative conditions, and for their recognition of our contributions to this effort.